The company introduced systems for single-cell proteomics, clinical sample processing, and spatial proteomics.
MGI Tech Co Ltd presented its latest developments in laboratory automation and integrated workflow solutions at the Society for Laboratory Automation and Screening (SLAS) 2026 event in Vienna, Austria. The portfolio includes systems designed to assist with research efficiency and simplify workflows in proteomics and clinical laboratory automation.
“SLAS provides an excellent platform to demonstrate how intelligent automation is transforming life science research and clinical laboratory operations,” says a spokesperson for MGI Tech, in a release. “Our latest solutions are designed to help laboratories uvercome workflow complexity, improve scalability, and accelerate scientific discovery across rapidly evolving research areas such as single-cell proteomics and organoid biology.”
Single-Cell Proteomics Automation
The PrepALL-pP8G is an extension of the PrepALL platform intended for single-cell proteomics sample pretreatment. According to MGI Tech, the system uses thermal inkjet printing and high-precision ultra-low volume dispensing to automate workflows from single-cell sorting to sample preparation.
The platform features 640 independent parallel nozzles and artificial intelligence (AI)-assisted camera vision to process 384-well plates. The system is designed to preserve cell viability and protein integrity during sorting and supports label-free, labeled, and conventional proteomics workflows. The European launch for the PrepALL-pP8G is expected in the second half of 2026.
Clinical Sample Processing
The company also showcased the GenSIRO48, a fully automated sample processing system making its international debut. The system is designed to provide a “Sample In, Report Out” solution by integrating nucleic acid purification, fragmentation, end repair, adapter ligation, polymerase chain reaction amplification, and library purification and quality control.
The GenSIRO48 is designed to process 48 samples in parallel, moving from manual intervention to unattended execution. According to the company, the system is built for use in clinical molecular diagnosis, public health prevention, and life science research scenarios.
Spatial Proteomics and Imaging
The VisiOmics is an automated staining and imaging system making its European debut. It uses multiplex immune fluorescence technology to capture spatial protein expression data in tissue sections.
The system is integrated with an AI-powered analysis platform for cell segmentation, phenotyping, and spatial mapping. MGI Tech says the system provides a workflow for applications in tumor classification, prognosis, and translational research. The European launch for VisiOmics is scheduled for the second half of 2026.
Photo caption: SLAS 2026 group photo
Photo credit: MGI Tech Co Ltd
